Northwire Canada EditionSunday, October 18, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 109
  1. Nov 04, 2025 · 07:00 · 4875

    MediciNova Announces Completion of Patient Enrollment in MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

    MediciNova Announces Completion of Patient Enrollment in MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

    01
  2. Nov 04, 2025 · 03:16 · DTC

    Defence Therapeutics Demonstrates Strong Preclinical in Vivo Efficacy Results Evaluating Accum-Kadcyla in Breast Cancer Models

    Defence Therapeutics Demonstrates Strong Preclinical in Vivo Efficacy Results Evaluating Accum-Kadcyla in Breast Cancer Models

    02
  3. Nov 04, 2025 · 03:05 · BNXT

    BioNxt Reports "Intention to Grant" Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies

    BioNxt Reports "Intention to Grant" Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies

    03
  4. Nov 04, 2025 · 00:40 · EKG

    CardioComm Terminates Royalty Agreement and Enters into $512,000 Insider Loan Facility to Advance Gems Flex and 14-Day Holter/LTCM Platform

    CardioComm Terminates Royalty Agreement and Enters into $512,000 Insider Loan Facility to Advance Gems Flex and 14-Day Holter/LTCM Platform

    04
  5. Nov 03, 2025 · 19:13 · AIAI

    Netramark signs NetraAI contract with biopharm firm

    Netramark signs NetraAI contract with biopharm firm

    05
  6. Nov 03, 2025 · 17:54 · CRRX

    CareRx Reports Results for the Third Quarter of 2025

    CareRx Reports Results for the Third Quarter of 2025

    06
  7. Nov 03, 2025 · 16:39 · TLT

    Theralase says X-ray drug effective in cancer models

    Theralase says X-ray drug effective in cancer models

    07
  8. Nov 03, 2025 · 16:04 · NRX

    NurExone Accepted into ARMI's BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing

    NurExone Accepted into ARMI's BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing

    08
  9. Nov 03, 2025 · 08:30 · AIAI

    Netramark Signs Contract with a Leading Global Biopharmaceutical Company to Enhance Clinical Trial Insights

    Netramark Signs Contract with a Leading Global Biopharmaceutical Company to Enhance Clinical Trial Insights

    09
  10. Nov 03, 2025 · 07:45 · VVTM

    /R E P E A T -- VVT Med Receives Order from Major US Healthcare Network NorthWell Health and Enters Into Investor Relations Agreements/

    /R E P E A T -- VVT Med Receives Order from Major US Healthcare Network NorthWell Health and Enters Into Investor Relations Agreements/

    10
  11. Nov 03, 2025 · 07:03 · TLT

    Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug

    Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug

    11
  12. Oct 31, 2025 · 20:35 · ONCO

    Onco-Innovations sets out updates from the past months

    Onco-Innovations sets out updates from the past months

    12
  13. Oct 31, 2025 · 19:51 · QNTM

    Quantum BioPharma Ltd. Provides Corporate Update

    Quantum BioPharma Ltd. Provides Corporate Update

    13
  14. Oct 31, 2025 · 19:24 · GUD

    Knight Therapeutics closes revolving credit facility

    Knight Therapeutics closes revolving credit facility

    14
← Newer Older →